ID

13394

Descrição

Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00712686

Link

https://clinicaltrials.gov/show/NCT00712686

Palavras-chave

  1. 10/02/2016 10/02/2016 -
Transferido a

10 de fevereiro de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Schizophrenia NCT00712686

Eligibility Schizophrenia NCT00712686

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with dsm-iv diagnosis of schizophrenia patients in acute relapse
Descrição

schizophrenia relapse

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0036341
UMLS CUI [1,2]
C0277556
treated as outpatients for at least one continuous 3-month period during the past 12 months
Descrição

outpatients

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0029921
panss total score ≥60
Descrição

panss score

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0451383
previously responsive to neuroleptics (other than clozapine)
Descrição

neuroleptics

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0040615
able to give informed consent and comprehend and satisfactorily comply with the protocol requirements
Descrição

informed consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
an axis i (dsm-iv) diagnosis of schizoaffective disorder
Descrição

schizoaffective disorder

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0036337
a clinical picture and/or history that was consistent with: (a) delirium, dementia, amnestic or other cognitive disorders; (b) bipolar disorder; (c)personality disorder
Descrição

mental disorders

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0004936
nonresponsive to prior olanzapine therapy
Descrição

olanzapine response

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0171023
UMLS CUI [1,2]
C1704632
likely to require prohibited concomitant therapy
Descrição

therapy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0087111
dsm-iv criteria for any significant substance abuse within the past three months, including addiction to cocaine or alcohol
Descrição

substance abuse

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0038586
known to be allergic or hypersensitive to study drugs
Descrição

hypersensitivity

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0020517
represented a significant risk of committing suicide based on history or mental status exam
Descrição

suicidal

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0438696
unstable thyroid pathology and treatment within the past six months
Descrição

thyroid disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0040128
a history or evidence of a medical condition that would expose the patient to an undue risk
Descrição

comorbidity

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0009488
clinically significant abnormal laboratory test results (including urine drug screen), vital sign, or ecg findings
Descrição

health status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0018759

Similar models

Eligibility Schizophrenia NCT00712686

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
schizophrenia relapse
Item
patients with dsm-iv diagnosis of schizophrenia patients in acute relapse
boolean
C0036341 (UMLS CUI [1,1])
C0277556 (UMLS CUI [1,2])
outpatients
Item
treated as outpatients for at least one continuous 3-month period during the past 12 months
boolean
C0029921 (UMLS CUI [1])
panss score
Item
panss total score ≥60
boolean
C0451383 (UMLS CUI [1])
neuroleptics
Item
previously responsive to neuroleptics (other than clozapine)
boolean
C0040615 (UMLS CUI [1])
informed consent
Item
able to give informed consent and comprehend and satisfactorily comply with the protocol requirements
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
schizoaffective disorder
Item
an axis i (dsm-iv) diagnosis of schizoaffective disorder
boolean
C0036337 (UMLS CUI [1])
mental disorders
Item
a clinical picture and/or history that was consistent with: (a) delirium, dementia, amnestic or other cognitive disorders; (b) bipolar disorder; (c)personality disorder
boolean
C0004936 (UMLS CUI [1])
olanzapine response
Item
nonresponsive to prior olanzapine therapy
boolean
C0171023 (UMLS CUI [1,1])
C1704632 (UMLS CUI [1,2])
therapy
Item
likely to require prohibited concomitant therapy
boolean
C0087111 (UMLS CUI [1])
substance abuse
Item
dsm-iv criteria for any significant substance abuse within the past three months, including addiction to cocaine or alcohol
boolean
C0038586 (UMLS CUI [1])
hypersensitivity
Item
known to be allergic or hypersensitive to study drugs
boolean
C0020517 (UMLS CUI [1])
suicidal
Item
represented a significant risk of committing suicide based on history or mental status exam
boolean
C0438696 (UMLS CUI [1])
thyroid disease
Item
unstable thyroid pathology and treatment within the past six months
boolean
C0040128 (UMLS CUI [1])
comorbidity
Item
a history or evidence of a medical condition that would expose the patient to an undue risk
boolean
C0009488 (UMLS CUI [1])
health status
Item
clinically significant abnormal laboratory test results (including urine drug screen), vital sign, or ecg findings
boolean
C0018759 (UMLS CUI [1])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial